Not applicableStudy completedNCT02029105What this trial is testingSerum Biomarkers in Diagnosis of MesotheliomaWho this might be right forMesothelioma Eskisehir Osmangazi University 230
Early research (Phase 1)Ended earlyNCT02465983What this trial is testingPilot Study of Autologous T-cells in Patients With Metastatic Pancreatic CancerWho this might be right forPancreatic Cancer University of Pennsylvania 4
Testing effectiveness (Phase 2)Study completedNCT02004262What this trial is testingSafety and Efficacy of Combination Listeria/GVAX Pancreas Vaccine in the Pancreatic Cancer SettingWho this might be right for2nd-line, 3rd-line and Greater Metastatic Pancreatic Cancer Aduro Biotech, Inc. 303
Early research (Phase 1)UnknownNCT03545815What this trial is testingStudy of CRISPR-Cas9 Mediated PD-1 and TCR Gene-knocked Out Mesothelin-directed CAR-T Cells in Patients With Mesothelin Positive Multiple Solid Tumors.Who this might be right forSolid Tumor, Adult Chinese PLA General Hospital 10
Early research (Phase 1)WithdrawnNCT00024674What this trial is testingStudy of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: Continuous Infusion for 10 DaysWho this might be right forNeoplasms INSYS Therapeutics Inc
Early research (Phase 1)Study completedNCT02639091What this trial is testingPhase Ib Study of Anetumab Ravtansine in Combination With Pemetrexed and Cisplatin in Mesothelin-expressing Solid TumorsWho this might be right forMedical Oncology Bayer 36
Early research (Phase 1)Ended earlyNCT05623488What this trial is testingCAR T Cells in Mesothelin-Expressing Breast CancerWho this might be right forBreast Cancer University of Pennsylvania 2
Testing effectiveness (Phase 2)Looking for participantsNCT07510815What this trial is testingDual-Target MSLN/FAP CAR-NK Cells for Pleural and Peritoneal MesotheliomaWho this might be right forMalignant Pleural Mesotheliomas Beijing Biotech 36
Testing effectiveness (Phase 2)Looking for participantsNCT07486089What this trial is testingDual-Target CAR-NK Cells for Advanced Breast Cancer (HER2+ and TNBC)Who this might be right forBreast Cancer (Locally Advanced or Metastatic)HER2-positive Breast CancerTriple-Negative Breast Cancer (TNBC) Beijing Biotech 60
Testing effectiveness (Phase 2)Looking for participantsNCT07510828What this trial is testingPRISM-NK: Precision-Matched Allogeneic Single- or Dual-Target CAR-NK Cells for Advanced Solid TumorsWho this might be right forAdvanced or Metastatic Solid Tumors Beijing Biotech 60
Testing effectiveness (Phase 2)Study completedNCT01417000What this trial is testingSafety and Efficacy of Combination Listeria/GVAX Immunotherapy in Pancreatic CancerWho this might be right forMetastatic Pancreatic Cancer Aduro Biotech, Inc. 93
Testing effectiveness (Phase 2)Looking for participantsNCT06051695What this trial is testingEvaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 ExpressionWho this might be right forSolid Tumor, AdultColorectal CancerNSCLC+17 more A2 Biotherapeutics Inc. 474
Very early researchUnknownNCT03267173What this trial is testingEvaluate the Safety and Efficacy of CAR-T in the Treatment of Pancreatic Cancer.Who this might be right forPancreatic CancerCAR First Affiliated Hospital of Harbin Medical University 10
Early research (Phase 1)Looking for participantsNCT06756035What this trial is testingCT-95 in Advanced Cancers Associated With Mesothelin ExpressionWho this might be right forMesothelin-Expressing TumorsEpithelial Ovarian CancerMalignant Pleural Mesothelioma, Advanced+8 more Context Therapeutics Inc. 70
Early research (Phase 1)Looking for participantsNCT06885697What this trial is testingAnti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including MesotheliomaWho this might be right forMesotheliomaNeoplasmsStomach Neoplasms+5 more National Cancer Institute (NCI) 100
Testing effectiveness (Phase 2)Ended earlyNCT05451849What this trial is testingA Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing CancerWho this might be right forMesotheliomaMesotheliomas PleuralMesothelioma, Malignant+14 more TCR2 Therapeutics 14
Testing effectiveness (Phase 2)Active Not RecruitingNCT03907852What this trial is testingPhase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing CancerWho this might be right forMesotheliomaMesothelioma, MalignantMesothelioma; Pleura+8 more TCR2 Therapeutics 57
Early research (Phase 1)Study completedNCT01897415What this trial is testingAutologous Redirected RNA Meso CAR T Cells for Pancreatic CancerWho this might be right forSubjects With Metastatic Pancreatic Ductal Adenocarcinoma (PDA) University of Pennsylvania 16
Testing effectiveness (Phase 2)Looking for participantsNCT07480954What this trial is testingDual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16)Who this might be right forEpithelial Ovarian CancerPrimary Peritoneal CarcinomaFallopian Tube Carcinoma+1 more Beijing Biotech 36
Testing effectiveness (Phase 2)Ended earlyNCT03926143What this trial is testingA Clinical Study of Anetumab Ravtansine in Adults With Solid Tumors Who Have Been Treated in Previous Bayer-sponsored Anetumab Ravtansine StudiesWho this might be right forSolid Tumors Bayer 9